Ubiquitin-proteasome system dysregulation in FAM111B-related poikiloderma and phenotypic spectrum expansion: new case
Virginie Vignard1, Mike Maillasson2, Anne Bigot3
1Nantes Université, CNRS, INSERM, l'institut du Thorax, Nantes 44000, France.
Insights
Hereditary fibrosing disorder POIKTMP, caused by FAM111B mutations, involves a dysfunctional ubiquitin-proteasome system (UPS). This discovery offers new therapeutic targets for POIKTMP patients.
Area of Science:
- Genetics and Molecular Biology
- Rare Diseases
- Cellular Biology
Background:
- Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) is a rare genetic disorder linked to FAM111B gene mutations.
- The molecular mechanisms underlying POIKTMP are not well understood.
- FAM111B, a serine protease, has roles beyond cancer, as indicated by germline variants not consistently associated with tumors.
Purpose of the Study:
- To elucidate the molecular pathogenesis of POIKTMP.
- To expand the understanding of the clinical spectrum and genetic basis of POIKTMP.
Main Methods:
- Clinical data from 41 POIKTMP patients, including 4 new cases, were compiled and compared.
- Functional studies utilized omics technologies on patient-derived cells with FAM111B missense variants.
Main Results:
- The POIKTMP phenotype includes renal failure, dental anomalies, hypoparathyroidism, and neuropathy.
- FAM111B variants in the D-box domain correlate with a more severe clinical presentation.
- Loss of FAM111B expression disrupts the ubiquitin-proteasome system (UPS), increasing ubiquitin-protein conjugates and inducing a type I interferon signature.
Conclusions:
- A dysfunctional UPS is implicated as a key driver in POIKTMP molecular pathogenesis.
- These findings suggest potential therapeutic strategies targeting UPS dysfunction for POIKTMP.
Background:
Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) is a rare genetic multisystemic fibrosing disorder caused by FAM111B gene mutations. Given its rarity, the molecular underpinnings of POIKTMP remain elusive. FAM111B, a trypsin-like serine protease, initially studied in cancer, exhibits germline variants not consistently linked to tumours, suggesting broader functions beyond cell proliferation.
Methods:
In this study, we compiled and compared the clinical features of 41 POIKTMP patients, which included the description of 4 newly identified cases. Functional studies involved the exploration of patient-derived cells carrying FAM111B missense variants using omics technologies.
Findings:
Our results show that the phenotypic spectrum of POIKTMP encompassed renal failure, dental anomalies, hypoparathyroidism, and potentially neuropathy. Notably, variants clustering within the D-box domain of FAM111B protein tend to present a more severe phenotype. Most importantly, loss of FAM111B expression perturbed ubiquitin-proteasome system (UPS) function, leading to increased content of ubiquitin-protein conjugates and a sterile type I interferon signature.
Interpretation:
These findings highlight a dysfunctional UPS as a potential central driver of POIKTMP's molecular pathogenesis, presenting promising therapeutic avenues.
Funding:
Association Française contre les Myopathies (AFM - 20760), Fondation Génavie (657298), Fondation Thellie, I-SITE NExT Junior Talent, Biogenouest, Infrastructures en Biologie Santé et Agronomie (IBiSA) and Conseil Régional de Bretagne.
More Related Videos
Related Concept Videos
Pleiotropy
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Pedigree Analysis
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Lysosomal Hydrolases


